---
figid: PMC12156458__molecules-30-02353-g002
figtitle: Blocking the JNK signaling pathway with JNK inhibitors and indirect biological
  modulators after cerebral I/R
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12156458
filename: molecules-30-02353-g002.jpg
figlink: /pmc/articles/PMC12156458/figure/F2/
number: F2
caption: 'Blocking the JNK signaling pathway with JNK inhibitors and indirect biological
  modulators after cerebral I/R. Blocking ROS or JNK activity with JNK inhibitors
  restores BBB, most likely by interfering with the secretion of proinflammatory and
  proapoptotic mediators in cells of neurovascular unit and blocking apoptotic signaling
  pathways. Abbreviations: AP-1, transcription factor activator protein 1; ATRA, all-trans
  retinoic acid; BBB, blood–brain barrier; BMS309403, a selective A-FABP inhibitor;
  20-HETE, 20-hydroxyeicosatetraenoic acid; HET0016 and TS-011, inhibitors of 20-HETE
  synthesis; I/R, ischemia/reperfusion; JNK, c-Jun N-terminal kinase; MKK4, mitogen-activated
  protein kinase kinase 4; NRG-1β, neuregulin 1β; A-FABP, fatty acid-binding protein;
  MMP-9, matrix metalloproteinase-9; ROCK, Rho-associated coiled-coil containing protein
  kinase; ROS, reactive oxygen species; TNF, tumor necrosis factor; TJ, tight junction;
  Tryp-Ox, tryptanthrin-6-oxime'
papertitle: 'Regulation of Blood–Brain Barrier Permeability via JNK Signaling Pathway:
  Mechanisms and Potential Therapeutic Strategies for Ischemic Stroke, Alzheimer’s
  Disease and Brain Tumors'
reftext: Mark B. Plotnikov, et al. Molecules. 2025 Jun;30(11).
year: '2025'
doi: 10.3390/molecules30112353
journal_title: Molecules
journal_nlm_ta: Molecules
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: Alzheimer’s disease | blood–brain barrier | brain tumor | ischemia/reperfusion
  | c-Jun N-terminal kinase (JNK) | JNK pathway | JNK inhibitor
automl_pathway: 0.9087061
figid_alias: PMC12156458__F2
figtype: Figure
redirect_from: /figures/PMC12156458__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12156458__molecules-30-02353-g002.html
  '@type': Dataset
  description: 'Blocking the JNK signaling pathway with JNK inhibitors and indirect
    biological modulators after cerebral I/R. Blocking ROS or JNK activity with JNK
    inhibitors restores BBB, most likely by interfering with the secretion of proinflammatory
    and proapoptotic mediators in cells of neurovascular unit and blocking apoptotic
    signaling pathways. Abbreviations: AP-1, transcription factor activator protein
    1; ATRA, all-trans retinoic acid; BBB, blood–brain barrier; BMS309403, a selective
    A-FABP inhibitor; 20-HETE, 20-hydroxyeicosatetraenoic acid; HET0016 and TS-011,
    inhibitors of 20-HETE synthesis; I/R, ischemia/reperfusion; JNK, c-Jun N-terminal
    kinase; MKK4, mitogen-activated protein kinase kinase 4; NRG-1β, neuregulin 1β;
    A-FABP, fatty acid-binding protein; MMP-9, matrix metalloproteinase-9; ROCK, Rho-associated
    coiled-coil containing protein kinase; ROS, reactive oxygen species; TNF, tumor
    necrosis factor; TJ, tight junction; Tryp-Ox, tryptanthrin-6-oxime'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K4
  - NRG1
  - MAPK8
  - MAPK9
  - MAPK10
  - ROCK1
  - ROCK2
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - MMP9
  - TNF
  - Melatonin
  - Anethole
  - ROS
  - Metformin
  - 20-HETE
  - Dexmedetomidine
  - Levofloxacin
  - SP600125
  - Fasudil
---
